EA200602206A1 - Инактивация патогена в препарате путем обработки формалином и уф светом - Google Patents

Инактивация патогена в препарате путем обработки формалином и уф светом

Info

Publication number
EA200602206A1
EA200602206A1 EA200602206A EA200602206A EA200602206A1 EA 200602206 A1 EA200602206 A1 EA 200602206A1 EA 200602206 A EA200602206 A EA 200602206A EA 200602206 A EA200602206 A EA 200602206A EA 200602206 A1 EA200602206 A1 EA 200602206A1
Authority
EA
Eurasian Patent Office
Prior art keywords
formalin
light
pathogen
inactivation
drug
Prior art date
Application number
EA200602206A
Other languages
English (en)
Other versions
EA010428B1 (ru
Inventor
Манфред Райтер
Вольфганг Мундт
Ноэль Барретт
Отфрид Кистнер
Original Assignee
Бакстер Интернэшнл Инк.
Бакстер Хелткэр С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бакстер Интернэшнл Инк., Бакстер Хелткэр С.А. filed Critical Бакстер Интернэшнл Инк.
Publication of EA200602206A1 publication Critical patent/EA200602206A1/ru
Publication of EA010428B1 publication Critical patent/EA010428B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0029—Radiation
    • A61L2/0047—Ultraviolet radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M31/00—Means for providing, directing, scattering or concentrating light
    • C12M31/02—Means for providing, directing, scattering or concentrating light located outside the reactor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10—Apparatus features
    • A61L2202/11—Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Sustainable Development (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Настоящее изобретение относится к способу инактивации вируса в препарате посредством обработки содержащего вирус препарата эффективной концентрацией формалина и эффективной дозой УФ света в проточном устройстве.
EA200602206A 2004-05-27 2005-05-26 Инактивация патогена в препарате путем обработки формалином и уф светом EA010428B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57531004P 2004-05-27 2004-05-27
PCT/EP2005/005691 WO2005118000A1 (en) 2004-05-27 2005-05-26 Inactivation of a pathogen in a sample by a treatment with formalin and uv light

Publications (2)

Publication Number Publication Date
EA200602206A1 true EA200602206A1 (ru) 2007-04-27
EA010428B1 EA010428B1 (ru) 2008-08-29

Family

ID=34968615

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200602206A EA010428B1 (ru) 2004-05-27 2005-05-26 Инактивация патогена в препарате путем обработки формалином и уф светом

Country Status (18)

Country Link
EP (1) EP1753470B1 (ru)
JP (2) JP5502276B2 (ru)
KR (1) KR101483337B1 (ru)
CN (1) CN1956739B (ru)
AU (1) AU2005249204B2 (ru)
BR (1) BRPI0511467A (ru)
CA (1) CA2567336C (ru)
CR (1) CR8805A (ru)
EA (1) EA010428B1 (ru)
EC (1) ECSP067118A (ru)
ES (1) ES2553457T3 (ru)
HK (1) HK1105374A1 (ru)
IL (1) IL179262A (ru)
MX (1) MXPA06013633A (ru)
NO (1) NO20065912L (ru)
NZ (1) NZ551857A (ru)
WO (1) WO2005118000A1 (ru)
ZA (1) ZA200610490B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005118000A1 (en) * 2004-05-27 2005-12-15 Baxter International Inc. Inactivation of a pathogen in a sample by a treatment with formalin and uv light
GB0706507D0 (en) * 2007-04-03 2007-05-09 Medi Immune Ltd Protective device
CA2690673C (en) * 2007-06-15 2013-04-23 Amgen Inc. Methods of treating cell culture media for use in a bioreactor
CN102858961A (zh) * 2010-05-03 2013-01-02 葛兰素史密丝克莱恩生物有限公司 新方法
JP5968795B2 (ja) * 2013-01-10 2016-08-10 四国化工機株式会社 紫外線殺菌装置
CN103992936B (zh) * 2014-04-22 2015-10-07 北京科兴生物制品有限公司 一种封闭式甲醛灭活病毒管道系统及其应用
EP3829668A2 (en) 2018-07-27 2021-06-09 Terumo BCT Biotechnologies, LLC Fluid flow-through
CN111840596B (zh) * 2020-06-11 2022-03-11 南岳生物制药有限公司 核黄素光化学血浆灭活装置及其控制系统、控制方法
WO2022024589A1 (ja) 2020-07-27 2022-02-03 国立研究開発法人理化学研究所 感染防止装置及び感染防止方法
CN114229953B (zh) * 2021-12-25 2022-11-18 无锡诚源环境科技有限公司 腔体式紫外消毒器的紫外线剂量计算方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB802048A (en) * 1955-08-26 1958-09-24 Parke Davis & Co Vaccine products and method for producing the same
US3926556A (en) * 1973-05-30 1975-12-16 Raymond Marcel Gut Boucher Biocidal electromagnetic synergistic process
SU1367487A1 (ru) * 1986-01-29 1995-10-27 Институт полиомиелита и вирусных энцефалитов АМН СССР Способ получения антирабической вакцины
US5247178A (en) * 1991-12-12 1993-09-21 Fusion Systems Corporation Method and apparatus for treating fluids by focusing reflected light on a thin fluid layer
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
DE10056096A1 (de) * 2000-11-13 2002-06-13 Bayer Ag Vorrichtung zur Bestrahlung von Flüssigkeiten
WO2005118000A1 (en) * 2004-05-27 2005-12-15 Baxter International Inc. Inactivation of a pathogen in a sample by a treatment with formalin and uv light

Also Published As

Publication number Publication date
MXPA06013633A (es) 2007-03-23
CR8805A (es) 2007-06-19
WO2005118000A1 (en) 2005-12-15
JP2012143249A (ja) 2012-08-02
ES2553457T3 (es) 2015-12-09
EP1753470B1 (en) 2015-08-19
EP1753470A1 (en) 2007-02-21
IL179262A0 (en) 2007-03-08
ZA200610490B (en) 2008-10-29
CA2567336C (en) 2010-11-23
AU2005249204A1 (en) 2005-12-15
ECSP067118A (ru) 2007-02-28
JP5502276B2 (ja) 2014-05-28
KR20110099810A (ko) 2011-09-08
NO20065912L (no) 2007-02-26
JP2008500303A (ja) 2008-01-10
CN1956739B (zh) 2011-12-28
BRPI0511467A (pt) 2007-12-26
NZ551857A (en) 2009-11-27
CN1956739A (zh) 2007-05-02
KR101483337B1 (ko) 2015-01-15
CA2567336A1 (en) 2005-12-15
EA010428B1 (ru) 2008-08-29
JP5675690B2 (ja) 2015-02-25
HK1105374A1 (en) 2008-02-15
AU2005249204B2 (en) 2010-07-15
IL179262A (en) 2011-01-31

Similar Documents

Publication Publication Date Title
EA200602206A1 (ru) Инактивация патогена в препарате путем обработки формалином и уф светом
CY1122291T1 (el) Αναστολeις ιικου αναδιπλασιασμου
TW200733953A (en) Materials and methods for treating viral infections
CY1120548T1 (el) Νανοσωματιδιο που περιλαμβανει ραπαμυκινη και αλβουμινη ως αντικαρκινικος παραγοντας
WO2007056720A3 (en) Air supply apparatus
MA33806B1 (fr) Inhibiteurs du virus de l'hepatite c
ATE460164T1 (de) Mittel zur behandlung von hyperlipidämie mit pitavastatinen und eicosapentaensäure
CY1114577T1 (el) Αποτροπη και θεραπεια υπο-κλινικης pcvd
EA201171208A1 (ru) Ингибиторы вируса гепатита с
EA201390190A1 (ru) Ингибиторы вируса гепатита с
EA200870164A1 (ru) Лечение вирусного гепатита
EA201370017A1 (ru) Ингибиторы вируса гепатита с
EA201170484A1 (ru) Терапевтический режим лечения гепатита, включающий пэг-интерферон, рибавирин и vx-950
CY1110162T1 (el) Φαρμακοτεχνικη μορφη και μεθοδοι για την αγωγη της θρομβοκυτταραιμιας
BRPI0512563A (pt) uso de um composto, e, métodos para o tratamento de um paciente e para exterminar microorganismos in vitro
DE602004029651D1 (de) Verwendung von artemisinin zur behandlung von durch onkogene viren gebildeten tumoren und zur behandlung von viralen infektionen
DE602008004317D1 (de) Verbindungen zur behandlung von hepatitis c
ATE525070T1 (de) Silbininkomponente zur behandlung von hepatitis
EA201391685A1 (ru) Ингибиторы вируса гепатита с
RU2015142783A (ru) Система и способ для инактивации вируса инфекционного панкреатического некроза (ipnv) посредством оптимизированного ультрафиолетового излучения
ATE555108T1 (de) Polyamide zur behandlung des menschlichen papilloma-virus
ATE469657T1 (de) Immunstimulatorische kombination zur vorbeugung und behandlung von hepatitis c
ATE401392T1 (de) Subtypabgestimmte inaktivierte vollvirusvakzine zur behandlung von patienten mit hiv-infektion
EA201071230A1 (ru) Лечение инфекций вирусом гепатита с телапревиром (vx-950) у пациентов, не отвечающих на лечение пегилированным интерфероном-альфа-2а/2в и рибавирином
EA200802358A1 (ru) Композиция для инактивации оболочечного вируса (варианты), способ лечения вирусного заболевания с ее помощью, средства на ее основе для изготовления лекарства против вирусного заболевания, для изготовления больших количеств биосовместимого дезинфецирующего средства и для изготовления покрытия, содержащий ее набор для инактивации оболочечного вируса и способ инактивации оболочечного вируса

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU